Insights on the Professional Services Global Market to 2030 - Identify Growth Segments for Investment
January 27, 2021 06:38 ET | Research and Markets
Dublin, Jan. 27, 2021 (GLOBE NEWSWIRE) -- The "Professional Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Denali Therapeutics to Highlight Progress Across Broad Biotherapeutics Portfolio for Neurodegeneration Enabled by Its Blood-Brain Barrier (BBB) TV Platform at Virtual R&D Day Today
October 15, 2020 08:00 ET | Denali Therapeutics Inc.
Proprietary and differentiated Transport Vehicle (TV) technology shows potential to solve the BBB challenge by delivering biotherapeutics to the brainNew preclinical data support the potential for...
Global Automated Test Equipment Market Report 2019-2026 Featuring LTX-Credence, Teradyne, Inc., and Advantest
October 12, 2020 05:29 ET | Research and Markets
Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The "Automated Test Equipment Market: By Type of Test Equipment, By End-User Application, and By Region - Global Industry Perspective, Comprehensive...
Enterprise Ventures Corporation Receives Initial $2.1 Million Order for Specialty Coatings for Military Applications
October 08, 2020 11:00 ET | Concurrent Technologies Corporation
Johnstown, PA, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Enterprise Ventures Corporation (EVC) has been awarded a $2.1 million contract to manufacture a proprietary specialty coating for military...
Nouveau copibec_4_coul.jpg
Hub Copibec : un appui financier de taille pour la blockchain et le droit d’auteur
August 25, 2020 15:37 ET | Copibec
MONTRÉAL, 25 août 2020 (GLOBE NEWSWIRE) -- Copibec et Scenarex sont heureux d’annoncer l’obtention des services-conseils et une contribution financière en vue d’un projet de recherche et...
August 17, 2020 07:00 ET | Mateon Therapeutics, Inc.
AGOURA HILLS, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics (OTC.QB: MATN), a leading developer of TGF-β therapeutics, announced financial results for the second quarter ended June...
Cytovance® Biologics Introduces an Integrated Single-use Platform for Plasmid DNA (pDNA) Manufacture
October 21, 2019 12:00 ET | Cytovance Biologics
OKLAHOMA CITY, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Cytovance Biologics is a leading biopharmaceutical CDMO with a 15-year track record of supplying drug substance to clients, offering fast and...
Cannabis Formulation Expert Darius Faizi, Ph.D. Joins Hydroponics, Inc. as Head of Research and Development
October 21, 2019 09:00 ET | Hydroponics, Inc.
NEWPORT BEACH, Calif., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Hydroponics, Inc., a national provider of agricultural supplies and logistics specific to the cannabis and hemp...
Vivos Inc. Issues Corrective Press Release Regarding Reverse Stock Split
June 27, 2019 15:07 ET | Vivos Inc.
Richland, WA, June 27, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...
Cytovance® Biologics Inc. appoints Dr. Jesse McCool as Chief Technology Officer
June 27, 2019 10:38 ET | Cytovance Biologics
Cytovance® Biologics Inc. announced that Dr. Jesse McCool will serve the company as CTO, effective June 27, 2019 OKLAHOMA CITY, June 27, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading...